Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study
Conclusions
GC was associated with a duration and dose-dependent increased risk of MACE in patients with RA. Very low dose prednisolone (<5 mg daily) did not appear to confer excessive CV risk.
Source: Annals of the Rheumatic Diseases - Category: Rheumatology Authors: So, H., Lam, T. O., Meng, H., Lam, S. H. M., Tam, L.-S. Tags: Editor's choice, ARD Lay summaries, ARD, Rheumatoid arthritis Source Type: research
More News: Arthritis | Cardiology | Cardiovascular | Databases & Libraries | Heart | Hong Kong Health | Men | Prednisolone | Rheumatoid Arthritis | Rheumatology | Study